MID-VOLUME · HOSP-MID
goserelin Side Effects
goserelin (also sold as Zoladex) sits MID-VOLUME #289 of 524 by FAERS report count. Lead signal: HOSP-MID - 29.8% mention hospitalization (3,830 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 12,855
- FAERS reports
FDA Adverse Event Reporting System extract for goserelin. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-MID. How figures are compiled.
goserelin: 29.8% mention hospitalization (3,830 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #289 of 524 by FAERS report count.
Mid-book FAERS page for goserelin (Zoladex) (12,855 reports). Signature HOSP-MID. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
DEATH leads 1,567 of 12,855 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (2,100 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (2,371 reports, 18.4%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 1,563 |
| MALIGNANT NEOPLASM PROGRESSION | 147 |
| METASTASES TO BONE | 78 |
| FATIGUE | 75 |
| ASTHENIA | 71 |
| DYSPNOEA | 68 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 66 |
| PROSTATE CANCER | 65 |
| ANAEMIA | 64 |
| DISEASE PROGRESSION | 60 |
| PNEUMONIA | 52 |
| PROSTATE CANCER METASTATIC | 52 |
| NAUSEA | 51 |
| PAIN | 51 |
| FALL | 45 |
| NEUTROPENIA | 45 |
| METASTASES TO LIVER | 41 |
| PYREXIA | 40 |
Reactions in Hospitalization Reports
Hospitalization mid-share (3,830, 29.8%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| FATIGUE | 218 |
| PNEUMONIA | 200 |
| DYSPNOEA | 196 |
| NAUSEA | 190 |
| ANAEMIA | 179 |
| PYREXIA | 177 |
| ASTHENIA | 176 |
| MALIGNANT NEOPLASM PROGRESSION | 176 |
| DIARRHOEA | 173 |
| VOMITING | 164 |
| FALL | 159 |
| PAIN | 158 |
| MALAISE | 145 |
| METASTASES TO BONE | 125 |
| DEATH | 123 |
| HYPERTENSION | 122 |
| NEUTROPENIA | 122 |
| DECREASED APPETITE | 115 |
| DIZZINESS | 115 |
| HEADACHE | 115 |
How to read goserelin FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-MID)
FAERS holds 12,855 voluntary reports linked to goserelin (Zoladex), 2004-2025. Death is listed on 2,371 (18.4%). Hospitalization appears on 3,830 (29.8%). Top co-reported indication: Prostate Cancer.
Mid-volume extract - treat DEATH-HEAVY · HOSP-MID as signal-detection rates next to 29.8% mention hospitalization (3,830 reports).
Read with goserelin
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 12,807 FAERS cases (Δ 48 lighter vs goserelin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 12,794 FAERS cases (Δ 61 lighter vs goserelin); DEATH-HEAVY · HOSP-HEAVY · MALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 12,919 FAERS cases (Δ 64 heavier vs goserelin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 12,758 FAERS cases (Δ 97 lighter vs goserelin); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 43.7 pp vs goserelin's DEATH-HEAVY): CASELOAD · HOSP-MID.
goserelin stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.